Study 10 of 21Eloralintide literatureLancet (London, England) · Phase 2Top journal2025
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial.
Not reported in abstract.
Where it sits
this study against the rest of the eloralintide corpus2
Preclinical · this one
17
Observational
0
Open-label
0
Randomised
2
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
Phase 22025
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Eloralintide corpus
BLinks between personality functioning and post-traumatic stress disorder symptoms: a network analysis.European journal of psychotraumatology · 2026 · n=1899 · E=0.31HumanBDrivers of farmers' intentions to adopt genome-edited cassava resistant to cassava brown streak disease in Uganda.GM crops & food · 2026 · n=357 · Not reported in abstract.HumanBBarriers to satisfactory primary care contacts for Swedish cancer survivors: a cross-sectional survey.Scandinavian journal of primary health care · 2023 · n=2131 · 67% (1429/2131) reported one or more barriers to satisfactory primary care contacts.HumanBDistinct correlates of post-traumatic stress disorder and subthreshold post-traumatic stress disorder considering a broad range of adverse experiences.European journal of psychotraumatology · 2026 · n=500 · PTSD prevalence was 15.0% among trauma-exposed individuals, n=461.HumanBReal-world creatine supplementation: a large-scale cross-sectional study of use, knowledge, and experiences.Journal of the International Society of Sports Nutrition · 2026 · n=2178 · Mean satisfaction of 7.8/10.HumanBHealth service delivery and disease management across Ethiopian health care facilities: An evidence-based analysis of tuberculosis program performance and system determinants.Dialogues in health · 2026 · n=112 · Pediatric TB detection was 2.1% vs. WHO's 12%.review